Skip to content
All Sections
Subscribe Now
55°F
Thursday, June 20th 2024
Today's E-Edition
Home Page
Close Menu
Business
Technology
Commercial Real Estate
Housing
Marketplace
The Mercury News
SUBSCRIBE NOW
Close Menu
Morning Report in your inbox!
Sign Up
Subscribe
Account Settings
Contact Us
Log Out
Spoof a user
Morning Report in your inbox!
Sign Up
Subscribe
Search
Silicon Valley
55°F
Thursday, June 20th 2024
Today's E-Edition
Business
Technology
Commercial Real Estate
Housing
Marketplace
The Mercury News
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Capricor Therap
(NQ:
CAPR
)
4.840
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
4.840
Bid (Size)
4.700 (5)
Ask (Size)
5.920 (3)
Prev. Close
4.840
Today's Range
4.840 - 4.840
52wk Range
2.680 - 8.221
Shares Outstanding
31,811,470
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 11, 2024
Via
Benzinga
What's Going On With Capricor Therapeutics Stock Tuesday?
June 11, 2024
Capricor Therapeutics announced successful completion of a Type-B meeting with the U.S. Food and Drug Administration (FDA).
Via
Benzinga
Performance
YTD
-5.47%
-5.47%
1 Month
-23.17%
-23.17%
3 Month
-29.34%
-29.34%
6 Month
+11.01%
+11.01%
1 Year
-0.21%
-0.21%
More News
Read More
What's Going On With Capricor Therapeutics Stock Tuesday?
June 04, 2024
Via
Benzinga
Expert Ratings For Capricor Therapeutics
May 14, 2024
Via
Benzinga
CAPR Stock Earnings: Capricor Therapeutics Misses EPS, Misses Revenue for Q1 2024
May 13, 2024
Via
InvestorPlace
Recap: Capricor Therapeutics Q4 Earnings
February 29, 2024
Via
Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
Via
Benzinga
Capricor Therapeutics's Earnings Outlook
February 28, 2024
Via
Benzinga
Preview: Capricor Therapeutics's Earnings
November 13, 2023
Via
Benzinga
Recap: Capricor Therapeutics Q1 Earnings
May 11, 2023
Via
Benzinga
Earnings Preview For Capricor Therapeutics
March 14, 2023
Via
Benzinga
FlexShopper And 3 Other Penny Stocks Insiders Are Buying
October 12, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Cadrenal Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying
October 09, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Turn Lower; Dow Tumbles Over 200 Points
September 29, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 29, 2023
Via
Benzinga
Crude Oil Down 1% Following PCE Data; Blue Apron Shares Surge
September 29, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Nasdaq Gains Over 1%; Nike Posts Upbeat Earnings
September 29, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 29, 2023
Via
Benzinga
Top 5 Health Care Stocks That May Fall Off A Cliff
August 23, 2023
Via
Benzinga
Earnings Scheduled For March 15, 2023
March 15, 2023
Via
Benzinga
Capricor Highlights Preclinical Data From Its Closed COVID-19 Vaccine Study
January 12, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022
October 26, 2022
Via
Benzinga
Recap of Tuesday's Biotech Catalysts - End Of The Day Summary
July 19, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close